TBPH - Theravance Biopharma Inc. (TBPH) Q1 2024 Earnings Call Transcript
2024-05-13 18:58:02 ET
Theravance Biopharma, Inc. (TBPH)
Q1 2024 Earnings Call Transcript
May 13, 2024 05:00 PM ET
Company Participants
Rick Winningham - Chief Executive Officer
Aine Miller - Head, Development
Rhonda Farnum - Chief Business Officer
Aziz Sawaf - Chief Financial Officer
Conference Call Participants
Douglas Tsao - H.C. Wainwright
Julian Harrison - BTIG
David Risinger - Leerink Partners
Marc Frahm - TD Cowen
Presentation
Operator
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma First Quarter 2024 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company's formal remarks. [Operator Instructions] I will repeat the instructions after the management completes their prepared remarks. Also, today's conference call is being recorded.
And now, I would like to turn the call over to Rick Winningham, Chief Executive Officer. Please go ahead, sir.
Rick Winningham
Good afternoon and welcome to Theravance Biopharma's first quarter 2024 earnings results conference call. On Slide 2, you'll find our safe harbor language and I'd remind everyone that are called today will include forward-looking statements involving risks and uncertainties pertaining to our development pipeline, expected benefits of our product candidate, anticipated timing of clinical trials, regulatory filings, and expected financial results. Information concerning factors that could cause results to differ materially from our forward-looking statements is described further in our filings with the SEC....
Theravance Biopharma, Inc. (TBPH) Q1 2024 Earnings Call Transcript